Evidence map›Paper›PMID 30523025›Full record

ArticleDiabetes2019

PDK4 Augments ER-Mitochondria Contact to Dampen Skeletal Muscle Insulin Signaling During Obesity.

Themis Thoudam, Chae-Myeong Ha, Jaechan Leem, Dipanjan Chanda, Jong-Seok Park, Hyo-Jeong Kim, Jae-Han Jeon, Yeon-Kyung Choi, Suthat Liangpunsakul, Yang Hoon Huh and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. The two faces of mitochondrial CaJournal of physiology and biochemistry · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in genetics · 2026
    Article
  16. Mitochondrial medicine in obesity: a scoping review.Open medicine (Warsaw, Poland) · 2026
    Review
  17. Article
  18. Article
  19. Review
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

Themis ThoudamDepartment of Biomedical Science, The Graduate School, Kyungpook National University, Daegu, Republic of Korea.
Chae-Myeong HaDepartment of Biomedical Science, The Graduate School, Kyungpook National University, Daegu, Republic of Korea.
Jaechan LeemDepartment of Immunology, School of Medicine, Catholic University of Daegu, Daegu, Republic of Korea.
Dipanjan ChandaLeading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea.
Jong-Seok ParkDepartment of Chemistry, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
Hyo-Jeong KimElectron Microscopy Research Center, Korea Basic Science Institute, Ochang, Chungbuk, Republic of Korea.
Jae-Han JeonLeading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea.
Yeon-Kyung ChoiLeading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea.
Suthat LiangpunsakulDivision of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
Yang Hoon HuhElectron Microscopy Research Center, Korea Basic Science Institute, Ochang, Chungbuk, Republic of Korea.
Tae-Hwan KwonDepartment of Biomedical Science, The Graduate School, Kyungpook National University, Daegu, Republic of Korea.
Keun-Gyu ParkLeading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea.ORCID 0000-0002-8403-1298
Robert A HarrisDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN.
Kyu-Sang ParkDepartment of Physiology, Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine, Gangwon-Do, Republic of Korea.
Hyun-Woo RheeDepartment of Chemistry, Seoul National University, Seoul, Republic of Korea.
In-Kyu LeeLeading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea leei@knu.ac.kr.ORCID 0000-0002-2261-7269
Kyungpook National University Hospital · KRKyungpook National University · KRKorea Basic Science Institute · KRYonsei University · KRDaegu Catholic University · KRIndiana University School of MedicineRichard L. Roudebush VA Medical Center · USSeoul National University · KRUlsan National Institute of Science and Technology · KR

Funding

Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)U01AA021840 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI NAGA P CHALASANI, Olawale Ojo · 2012 to 2026
$8.1M
Novel biomarkers as a clinical tool for excessive alcohol use screeningR01AA025208 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT, TU, WANZHU · 2016 to 2020
$1.7M
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver diseaseR01DK107682 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DONG, X. CHARLIE, LIANGPUNSAKUL, SUTHAT · 2016 to 2019
$1.4M
Long noncoding RNAs in alcoholic liver diseaseR21AA024935 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT, WANG, LI · 2016 to 2017
$431k
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol ConsumptionI01CX000361 · VA · RLR VA MEDICAL CENTER · PI LIANGPUNSAKUL, SUTHAT · 2012 to 2025
–
CSRD VA I01 CX000361NIAAA NIH HHS R01 AA025208NIAAA NIH HHS R21 AA024935NIAAA NIH HHS U01 AA021840NIDDK NIH HHS R01 DK107682
6 · The paper itself

Abstract

Mitochondria-associated endoplasmic reticulum membrane (MAM) is a structural link between mitochondria and endoplasmic reticulum (ER). MAM regulates Ca

Indexed as

AnimalsCalciumCell LineEndoplasmic Reticulum StressImmunoblottingImmunoprecipitationInsulinMaleMembrane Potential, MitochondrialMiceMice, Inbred C57BLMice, KnockoutMicroscopy, Electron, TransmissionMitochondriaMuscle, SkeletalObesityCalciumInsulinPdk4 protein, mouseProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinaseReactive Oxygen Species

Identifiers

PMID30523025
PMCPMC6385748
OpenAlexW2903416559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.